95 related articles for article (PubMed ID: 21880656)
1. In vivo imaging and noninvasive ablation of pyramidal neurons in adult NEX-CreERT2 mice.
Agarwal A; Dibaj P; Kassmann CM; Goebbels S; Nave KA; Schwab MH
Cereb Cortex; 2012 Jul; 22(7):1473-86. PubMed ID: 21880656
[TBL] [Abstract][Full Text] [Related]
2. Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice.
Goebbels S; Bormuth I; Bode U; Hermanson O; Schwab MH; Nave KA
Genesis; 2006 Dec; 44(12):611-21. PubMed ID: 17146780
[TBL] [Abstract][Full Text] [Related]
3. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
4. Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination.
Brockschnieder D; Lappe-Siefke C; Goebbels S; Boesl MR; Nave KA; Riethmacher D
Mol Cell Biol; 2004 Sep; 24(17):7636-42. PubMed ID: 15314171
[TBL] [Abstract][Full Text] [Related]
5. Inducible gene inactivation in neurons of the adult mouse forebrain.
Erdmann G; Schütz G; Berger S
BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
[TBL] [Abstract][Full Text] [Related]
6. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
Zhao J; Nassar MA; Gavazzi I; Wood JN
Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.
Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E
Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738
[TBL] [Abstract][Full Text] [Related]
9. Reliable Genetic Labeling of Adult-Born Dentate Granule Cells Using Ascl1 CreERT2 and Glast CreERT2 Murine Lines.
Yang SM; Alvarez DD; Schinder AF
J Neurosci; 2015 Nov; 35(46):15379-90. PubMed ID: 26586824
[TBL] [Abstract][Full Text] [Related]
10. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
[TBL] [Abstract][Full Text] [Related]
11. Olig2-positive progenitors in the embryonic spinal cord give rise not only to motoneurons and oligodendrocytes, but also to a subset of astrocytes and ependymal cells.
Masahira N; Takebayashi H; Ono K; Watanabe K; Ding L; Furusho M; Ogawa Y; Nabeshima Y; Alvarez-Buylla A; Shimizu K; Ikenaka K
Dev Biol; 2006 May; 293(2):358-69. PubMed ID: 16581057
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific conditional mutagenesis in mouse embryonic stem cell-derived neural cells and postmitotic neurons by direct delivery of biologically active Cre recombinase.
Haupt S; Edenhofer F; Peitz M; Leinhaas A; Brüstle O
Stem Cells; 2007 Jan; 25(1):181-8. PubMed ID: 16960133
[TBL] [Abstract][Full Text] [Related]
13. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration.
Buch T; Heppner FL; Tertilt C; Heinen TJ; Kremer M; Wunderlich FT; Jung S; Waisman A
Nat Methods; 2005 Jun; 2(6):419-26. PubMed ID: 15908920
[TBL] [Abstract][Full Text] [Related]
14. Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice.
Heimer-McGinn V; Young P
Genesis; 2011 Dec; 49(12):942-9. PubMed ID: 21671347
[TBL] [Abstract][Full Text] [Related]
15. Temporal regulation of Cre recombinase activity in neural stem cells.
Imayoshi I; Ohtsuka T; Metzger D; Chambon P; Kageyama R
Genesis; 2006 May; 44(5):233-8. PubMed ID: 16652364
[TBL] [Abstract][Full Text] [Related]
16. Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer.
Pruitt SC; Bailey KJ; Freeland A
Stem Cells; 2007 Dec; 25(12):3121-32. PubMed ID: 17717065
[TBL] [Abstract][Full Text] [Related]
17. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
[TBL] [Abstract][Full Text] [Related]
18. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
Hayashi S; McMahon AP
Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
[TBL] [Abstract][Full Text] [Related]
19. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
